Pharmacology Biochemistry and Behavior

Editorial
pp. 531-532(2)
Authors: Higgins G.A.; Fletcher P.J.

Molecular, pharmacological and functional diversity of 5-HT receptors
pp. 533-554(22)
Authors: Hoyer D.; Hannon J.P.; Martin¹ G.R.

The medical benefit of 5-HT research
pp. 555-568(14)
Authors: Jones B.J.; Blackburn T.P.

Subthalamic 5-HT_1A and 5-HT_1B receptor modulation of RU 24969-induced behavioral profile in rats
pp. 569-580(12)
Authors: Martinez-Price¹ D.L.; Geyer M.A.

Anxiogenic-like effect of serotonin_1B receptor stimulation in the rat elevated plus-maze
pp. 581-587(7)
Authors: Lin D.; Parsons L.H.

Specific labelling of serotonin 5-HT_1B receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [³H]GR125,743 - A pharmacological characterization
pp. 589-598(10)
Authors: Millan M.J.; Newman-Tancredi A.; Lochon S.; Touzard M.; Aubry S.; Audinot V.

Effect of SB-243213, a selective 5-HT_2C receptor antagonist, on the rat sleep profile - A comparison to paroxetine
pp. 599-605(7)
Authors: Smith M.I.; Piper D.C.; Duxon M.S.; Upton N.

Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT_2C receptors in vivo
pp. 607-613(7)
Authors: Di Matteo V.; Cacchio M.; Di Giulio C.; Di Giovanni G.; Esposito E.

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety
pp. 615-625(11)
Authors: Martin J.R.; Ballard T.M.; Higgins G.A.

Central 5-HT₄ receptors and dopamine-dependent motor behaviors: Searching for a functional role
pp. 627-633(7)
Authors: De Deurwaerdere P.; Cervo L.; Stinus L.; Spampinato U.

Effects of the 5-HT₇ receptor antagonist SB-258741 in animal models for schizophrenia
pp. 655-665(11)
Authors: Pouzet B.; Didriksen M.; Arnt J.

Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake - A pharmacological characterization of diverse classes of antidepressant agents
pp. 667-680(14)
Authors: Brocco M.; Dekeyne A.; Veiga S.; Girardon S.; Millan M.J.

Parabrachial infusion of d-fenfluramine reduces food intake - Blockade by the 5-HT_1B antagonist SB-216641
pp. 681-690(10)
Authors: Simansky K.J.; Nicklous D.M.

Serotonin 2C receptor agonists and the behavioural satiety sequence in mice
pp. 691-700(10)
Authors: Hewitt¹ K.N.; Lee M.D.; Dourish C.T.; Clifton P.G.

Estrous cycle and food availability affect feeding induced by amygdala 5-HT receptor blockade
pp. 701-707(7)
Authors: Parker G.C.; Bishop C.; Coscina D.V.

Hypothalamic paraventricular 5-hydroxytryptamine: Receptor-specific inhibition of NPY-stimulated eating and energy metabolism
pp. 709-716(8)
Authors: Currie P.J.; Coiro C.D.; Niyomchai T.; Lira A.; Farahmand F.

Activation of 5-HT_1B receptors in the nucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule
pp. 717-725(9)
Authors: Fletcher P.J.; Azampanah A.; Korth K.M.

Role of serotonin_2C receptors in the control of brain dopaminergic function
pp. 727-734(8)
Authors: Di Matteo V.; Cacchio M.; Di Giulio C.; Esposito E.

An investigation of the role of 5-HT_2C receptors in modifying ethanol self-administration behaviour
pp. 735-744(10)
Authors: Tomkins D.M.; Joharchi N.; Tampakeras M.; Martin J.R.; Wichmann J.; Higgins G.A.

Involvement of serotonin in nicotine dependence: Processes relevant to positive and negative regulation of drug intake
pp. 757-771(15)
Authors: Olausson P.; Engel J.A.; Soderpalm B.

5-Hydroxytryptamine and interval timing behaviour
pp. 773-785(13)
Authors: Ho M.-Y.; Velazquez-Martnez¹ D.N.; Bradshaw C.M.; Szabadi E.

Effect of 8-OH-DPAT on temporal discrimination following central 5-hydroxytryptamine depletion
pp. 787-793(7)
Authors: Body S.; Chiang T.-J.; Mobini S.; Ho M.-Y.; Bradshaw C.M.; Szabadi E.

Nicotinic-serotonergic interactions in brain and behaviour
pp. 795-805(11)
Authors: Seth P.; Cheeta S.; Tucci S.; File S.E.

Electrical stimulation of the dorsal and median raphe nuclei increases extracellular noradrenaline in rat hippocampus: Evidence for a 5-HT-independent mechanism
pp. 807-813(7)
Authors: Hajos-Korcsok E.; Sharp¹ T.

Alteration in 5-hydroxytryptamine agonist-induced behaviour following a corticosterone implant in adult rats
pp. 815-823(9)
Authors: Fone K.C.F.; Topham I.A.

Serotonin releasing agents - Neurochemical, therapeutic and adverse effects
pp. 825-836(12)
Authors: Rothman R.B.; Baumann M.H.

Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
pp. 837-844(8)
Author: Parrott A.C.

How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
pp. 845-855(11)
Author: Kish S.J.

The role of serotonin in human mood and social interaction - Insight from altered tryptophan levels
pp. 857-865(9)
Authors: Young S.N.; Leyton M.

Contents Volume 71, 2002
pp. 869-874(6)

Volume 71, 2002 Author Index
pp. 875-876(2)

Volume 71, 2002 Keyword Index
pp. 877-879(3)